Form 4 for AKTX Akari Therapeutics Plc
Accepted 2025-04-29 00:00:00 ET · period of report 2025-04-25 · accession 0000950170-25-060298 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-29 | 2025-03-06 | AKTX | Patel Sandip I | Dir | A - Grant | $1.12 | +44.6K | 496.5K | +10% | +$50.0K |
| DM | 2025-04-29 | 2025-03-06 | AKTX | Patel Sandip I | Dir | A - Grant | $1.12 | +89.3K | 44.6K | New | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares representing Ordinary Shares | 2025-03-06 | A | A | 44,642 | $1.12 | 496,499 | D | — | — | (F1) Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. (F2) On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. |
| 2 | Derivative | Series A Warrants (Right to Buy) | 2025-03-06 | A | A | 44,642 | $1.12 | 44,642 | D | $0.87 · 2025-03-06 to 2026-03-06 | 44,642 American Depositary Shares representing Ordinary Shares | (F2) On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. |
| 3 | Derivative | Series B Warrants (Right to Buy) | 2025-03-06 | A | A | 44,642 | $1.12 | 44,642 | D | $0.87 · 2025-03-06 to 2030-03-06 | 44,642 American Depositary Shares representing Ordinary Shares | (F2) On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. |